3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
4
HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane
1
Breast Cancer Invasive
1
Breast Cancer Female
1
Interventions
Tamoxifen
2
pyrotinib
1
exemestane
1
abemaciclib
1
Surgical Procedures, Operative
1
Radiotherapy
1
Radiation Dose Hypofractionation
1
Mammaplasty
1
Letrozole
1
Drug Therapy
1
Aromatase Inhibitors
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Breast Cancer Female
×
pyrotinib
×
Clear all
NCT04126525
2025-09-11
NeoATP
RenJi Hospital
Phase 2
Active not recruiting
53 enrolled